Oxidative stress and the therapeutic potential of dietary antioxidants in polycystic ovary syndrome: a narrative review
Abstract
It is becoming more well acknowledged that oxidative stress is a crucial component that connects the hormonal, metabolic, and reproductive aspects of polycystic ovarian syndrome (PCOS). A more holistic and natural approach to managing the illness might be possible through lowering this disparity. This review outlines new findings about the effects of dietary antioxidants on critical processes related to PCOS, such as insulin signaling, inflammation, and mitochondrial activity. Antioxidants that have demonstrated encouraging effects in reducing oxidative stress, insulin resistance, and ovulatory health include N-acetylcysteine, coenzyme Q10, α-lipoic acid, and vitamins C and E. However, it's challenging to draw definitive findings due to limited intervention periods and variances in the study's methodology. More thorough, deeper, and more extensive standardized trials should be the main emphasis of future studies. Taken together, the results indicate that dietary antioxidants have significant medicinal value to help women with PCOS regain redox equilibrium and enhance their overall metabolic and reproductive health.
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.